Literature DB >> 25888862

Retraction note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients.

.   

Abstract

Entities:  

Year:  2015        PMID: 25888862      PMCID: PMC4374186          DOI: 10.1186/s40001-015-0134-4

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


× No keyword cloud information.

Retraction

The Publisher and Editor regretfully retract this article [1] because the peer-review process was inappropriately influenced and compromised. As a result, the scientific integrity of the article cannot be guaranteed. A systematic and detailed investigation suggests that a third party was involved in supplying fabricated details of potential peer reviewers for a large number of manuscripts submitted to different journals. In accordance with recommendations from COPE we have retracted all affected published articles, including this one. It was not possible to determine beyond doubt that the authors of this particular article were aware of any third party attempts to manipulate peer review of their manuscript.
  1 in total

1.  Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients.

Authors:  Yushuang Luo; Zhanquan Li; Sen Cui; Cunfang Shen; Junhui Zhao; Milu Wu; Yuying Li; Miaozhou Wang; Rong Chen; Zhibo Liu; Ge Ri-Li
Journal:  Eur J Med Res       Date:  2014-09-16       Impact factor: 2.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.